Dr Kelvin Loh, managing director and chief executive of IHH, said:"Our results for Q2 2020 naturally reflected the unprecedented challenges from Covid-19… We saw the worst impact in April and May."
In Malaysia and Singapore, revenue fell 23 per cent and 24 per cent yoy to RM434.3 million and RM805.9 million respectively. But Dr Loh noted that as countries began to re-open in June, the group began seeing"a strong rebound in local patient volumes and were net profit positive for that month". However, it will continue to mitigate the impact by"creating new revenue streams, improving case mix, keeping tight cost and capital discipline while supporting governments". It expressed optimism that it will remain resilient.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: